P04-30. Sorting of infectious and non-infectious viral particles by Env-specific mAb

P04-30. Sorting of infectious and non-infectious viral particles by Env-specific mAb

Bibliographic Details
Main Authors:	Shattock R, Armanasco N, Buff V, Fischetti L, Stieh DJ
Format:	Article
Language:	English
Published:	BMC 2009-10-01
Series:	Retrovirology

Similar Items

High affinity mAb infusion can enhance maximum affinity maturation during HIV Env immunization
by: Peter Thomas, et al.
Published: (2024-04-01)

Env diversity-dependent protection of the attenuated equine infectious anaemia virus vaccine
by: Yuezhi Lin, et al.
Published: (2020-01-01)

Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs.
by: Marnie L Fusco, et al.
Published: (2015-06-01)

The Different Colors of mAbs in Solution
by: Alexandre Ambrogelly
Published: (2021-05-01)

Correction: Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs.
by: Marnie L Fusco, et al.
Published: (2015-10-01)

Hypoxia and viral infectious diseases
by: Richard Huang, et al.
Published: (2021-04-01)

Relationship between Uveal Inflammation and Viral Detection in 30 Cats with Feline Infectious Peritonitis
by: Mariano Carossino, et al.
Published: (2022-08-01)

Developments and Challenges for mAb-Based Therapeutics
by: Satoshi Ohtake, et al.
Published: (2013-08-01)

HIV-2-Infected Macrophages Produce and Accumulate Poorly Infectious Viral Particles
by: Ester Gea-Mallorquí, et al.
Published: (2020-07-01)

Novel viral vectors in infectious diseases.
by: Humphreys, I, et al.
Published: (2017)

Nanovaccines against Viral Infectious Diseases
by: Wen Tzuen Heng, et al.
Published: (2022-11-01)

Virulence-related comparative transcriptomics of infectious and non-infectious chlamydial particles
by: Thomas Beder, et al.
Published: (2018-08-01)

Infectious Aerosol Capture Mask as Environmental Control to Reduce Spread of Respiratory Viral Particles
by: Joshua L. Santarpia, et al.
Published: (2022-06-01)

Viral vector delivery of Env trimer immunogens
by: Parks CL, et al.
Published: (2012-09-01)

Rapid identification of anti-idiotypic mAbs with high affinity and diverse epitopes by rabbit single B-cell sorting-culture and cloning technology.
by: WeiYu Lin, et al.
Published: (2020-01-01)

Evolutionary analysis of the dynamics of viral infectious disease.
by: Pybus, O, et al.
Published: (2009)

Editorial: Zoonotic emerging viral infectious diseases
by: Ji-Ming Chen, et al.
Published: (2023-04-01)

Single-Round Infectious Particle Production by DNA-Launched Infectious Clones of Bungowannah Pestivirus
by: Anja Dalmann, et al.
Published: (2020-08-01)

Induction of nAbs and protection of mice immunized with VLP's expressing CHIKV env
by: K. Muthumani, et al.
Published: (2014-04-01)

P04-32. Differential regulation of secondary antibody responses to Gag and Env proteins
by: Tenbusch M, et al.
Published: (2009-10-01)

Box-Jenkins modelling of some viral infectious diseases /
by: 303826 Helfenstein, Ulrich

Novel and Alternative Therapeutic Strategies for Controlling Avian Viral Infectious Diseases: Focus on Infectious Bronchitis and Avian Influenza
by: Ghulam Abbas, et al.
Published: (2022-07-01)

Morphogenesis of Infectious hepatitis C virus particles
by: Tetsuro eSuzuki
Published: (2012-02-01)

P20-15. Evaluation of HIV-1 subtype B acute envelope-expressing infectious molecular clones
by: Arts EJ, et al.
Published: (2009-10-01)

The Role of Complement in the Mechanism of Action of Therapeutic Anti-Cancer mAbs
by: Josée Golay, et al.
Published: (2020-10-01)

The Characteristics of the HIV-1 Env Glycoprotein Are Linked With Viral Pathogenesis
by: Silvia Pérez-Yanes, et al.
Published: (2022-03-01)

N-Terminally Myristoylated Feline Foamy Virus Gag Allows Env-Independent Budding of Sub-Viral Particles
by: Yong-Boum Kim, et al.
Published: (2011-11-01)

A new strategy to count and sort neutrophil‐derived extracellular vesicles: Validation in infectious disorders
by: Amandine Bonifay, et al.
Published: (2022-04-01)

Structural Basis for Env Incorporation into HIV-1 Particles
by: R. Elliot Murphy, et al.
Published: (2020-07-01)

Comparison between internalizing anti-HER2 mAbs and non-internalizing anti-CEA mAbs in alpha-radioimmunotherapy of small volume peritoneal carcinomatosis using 212Pb.
by: Vincent Boudousq, et al.
Published: (2013-01-01)

Endoplasmic reticulum retention motif fused to recombinant anti-cancer monoclonal antibody (mAb) CO17-1A affects mAb expression and plant stress response.
by: Ilchan Song, et al.
Published: (2018-01-01)

Development of a Viral-Like Particle Candidate Vaccine Against Novel Variant Infectious Bursal Disease Virus
by: Yulong Wang, et al.
Published: (2021-02-01)

Editorial: Molecular pathogenesis and control of viral infectious diseases in children
by: Jiali Cao, et al.
Published: (2024-02-01)

Lateral Flow Immunoassays for Detecting Viral Infectious Antigens and Antibodies
by: Rowa Y. Alhabbab
Published: (2022-11-01)

Senotherapeutics: An emerging approach to the treatment of viral infectious diseases in the elderly
by: Zhiqiang Li, et al.
Published: (2023-03-01)

Back to BAC: The Use of Infectious Clone Technologies for Viral Mutagenesis
by: Robyn N. Hall, et al.
Published: (2012-02-01)

Biomaterials-based formulations and surfaces to combat viral infectious diseases
by: Sushma Kumari, et al.
Published: (2021-03-01)

Comparative pathogenicity of CA1737/04 and Mass infectious bronchitis virus genotypes in laying chickens
by: Ahmed Ali, et al.
Published: (2024-02-01)

Variable domain sequences of mAb with high affinity for a linear oligopeptide.
by: Hanke, T, et al.
Published: (1995)

Treatment of Marmoset Intracerebral Hemorrhage with Humanized Anti-HMGB1 mAb
by: Dengli Wang, et al.
Published: (2022-09-01)